Dr. Christian Thirion

Further involvements

• 28/03/2023

  • Poster
  • P 405

  Transgene expression knockdown in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene expression across passages

   Vaccines, Viral vectors and gene therapy
• 28/03/2023

  • Poster
  • P 402

  Towards HERV-H Env protein-based tumor stratification and intervention strategies

   Viral transformation and oncogenesis
• 28/03/2023

  • Poster
  • P 310

  Generation and characterization of an Adenoviral vaccine candidate expressing the pentameric complex of human cytomegalovirus

   Adaptive immunity, Vaccines
• 28/03/2023

  • Poster
  • P 299

  Ex vivo characterization of IE-1/pp65-expressing adenoviral vectors as potential T cell vaccine candidates for human Cytomegalvirus

   Adaptive immunity, Vaccines
• 29/03/2023

  14:45 – 15:00 12 Min. 3 Min.

  • Abstract Talk
  • O 072

  Long-lasting antibody delivery by a myotropic Adeno-Associated Virus (AAV) capsid variant – high serum levels, favourable glycosylation profile and protection from SARS-CoV-2 challenge

   SARS-CoV-2, Viral vectors and gene therapy